Shaji Kumar

7 ta ish

Mayo Clinic in Arizona

1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

   Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos +80

   Sharh maqola20224 iqtibos

   ABIABI:AkademIndex/2026.other.480204

2. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

   S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo +31

   Maqola20143 iqtibos

   ABIABI:AkademIndex/2026.other.466311

3. Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

   Mark Bustoros, Romanos Sklavenitis‐Pistofidis, Jihye Park +33

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.312695

4. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

   Michèle Cavo, Evangelos Terpos, Cristina Nanni +25

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.466312

5. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

   Elı́as Campo, Elaine S. Jaffe, James R. Cook +70

   Maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.480200

6. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

   Hervé Avet‐Loiseau, Faith E. Davies, Mehmet Samur +43

   Maqola20252 iqtibos

   ABIABI:AkademIndex/2026.other.480252

7. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report

   David Murray, Noemí Puig, Sigurður Y. Kristinsson +10

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.890026